Similar articles for PMID: 27919968

Year	Number of Results
1998	1
2001	2
2002	1
2004	2
2005	3
2006	3
2007	2
2008	4
2009	2
2010	2
2011	4
2012	6
2013	5
2014	9
2015	8
2016	9
2017	9
2018	15
2019	12
2020	9
2021	14
2022	9
2023	5
2024	0

1

Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.

Ohashi T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E. Ohashi T, et al. Anticancer Res. 2016 Dec;36(12):6457-6466. doi: 10.21873/anticanres.11244. Anticancer Res. 2016. PMID: 27919968

2

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.

Ohashi T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Imamura T, Kiuchi J, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E. Ohashi T, et al. Br J Cancer. 2017 Jan 17;116(2):218-226. doi: 10.1038/bjc.2016.394. Epub 2016 Nov 29. Br J Cancer. 2017. PMID: 27898655 Free PMC article.

3

PBK/TOPK Expression Predicts Prognosis in Oral Cancer.

Chang CF, Chen SL, Sung WW, Hsieh MJ, Hsu HT, Chen LH, Chen MK, Ko JL, Chen CJ, Chou MC. Chang CF, et al. Int J Mol Sci. 2016 Jun 24;17(7):1007. doi: 10.3390/ijms17071007. Int J Mol Sci. 2016. PMID: 27347940 Free PMC article.

4

PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.

Lei B, Qi W, Zhao Y, Li Y, Liu S, Xu X, Zhi C, Wan L, Shen H. Lei B, et al. Hum Pathol. 2015 Feb;46(2):217-24. doi: 10.1016/j.humpath.2014.07.026. Epub 2014 Oct 30. Hum Pathol. 2015. PMID: 25466965

5

PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.

Hu F, Gartenhaus RB, Eichberg D, Liu Z, Fang HB, Rapoport AP. Hu F, et al. Oncogene. 2010 Oct 7;29(40):5464-74. doi: 10.1038/onc.2010.275. Epub 2010 Jul 12. Oncogene. 2010. PMID: 20622899

6

Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.

Su TC, Chen CY, Tsai WC, Hsu HT, Yen HH, Sung WW, Chen CJ. Su TC, et al. PLoS One. 2018 Oct 4;13(10):e0204866. doi: 10.1371/journal.pone.0204866. eCollection 2018. PLoS One. 2018. PMID: 30286126 Free PMC article.

7

PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.

Lei B, Liu S, Qi W, Zhao Y, Li Y, Lin N, Xu X, Zhi C, Mei J, Yan Z, Wan L, Shen H. Lei B, et al. Histopathology. 2013 Nov;63(5):696-703. doi: 10.1111/his.12215. Epub 2013 Sep 11. Histopathology. 2013. PMID: 24025073

8

TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.

Jiang Y, Zhang J, Zhao J, Li Z, Chen H, Qiao Y, Chen X, Liu K, Dong Z. Jiang Y, et al. BMC Cancer. 2019 Dec 30;19(1):1264. doi: 10.1186/s12885-019-6453-z. BMC Cancer. 2019. PMID: 31888532 Free PMC article.

9

PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.

He F, Yan Q, Fan L, Liu Y, Cui J, Wang J, Wang L, Wang Y, Wang Z, Guo Y, Huang G. He F, et al. Hum Pathol. 2010 Mar;41(3):415-24. doi: 10.1016/j.humpath.2009.05.016. Epub 2009 Dec 1. Hum Pathol. 2010. PMID: 19954816

10

PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.

Liu Y, Liu H, Cao H, Song B, Zhang W, Zhang W. Liu Y, et al. Oncol Rep. 2015 Dec;34(6):3288-96. doi: 10.3892/or.2015.4308. Oncol Rep. 2015. PMID: 26503118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year